期刊文献+

不稳定型心绞痛患者联合降脂治疗对患者的影响

Effectiveness of Atorvastatin Co-administration with Ezetimibe in Patients with Unstable Angina
下载PDF
导出
摘要 目的通过分析不稳定型心绞痛患者单用阿托伐他汀或者依折麦布联合阿托伐他汀治疗对总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDLC)、高密度脂蛋白胆固醇(HDLC)、前列环素(PGI2)、血栓素A2(TXA2)及C反应蛋白(CRP)的影响,了解依折麦布联合阿托伐他汀治疗对调脂、保护血管内皮功能及减轻炎性反应的效果。方法随机选择2012年6月—2014年6月186例不稳定型心绞痛患者进行单用阿托伐他汀治疗(每晚口服阿托伐他汀20 mg)和联合药物治疗(每晚口服阿托伐他汀20 mg和依折麦布10 mg)。观察服药前及服药12周后的TC、TG、LDLC、HDLC、PGI2、TXA2及CRP的水平变化。结果两组治疗前TC、TG、LDLC、HDLC、PGI2、TXA2及CRP的水平元明显差别。治疗12周后与治疗前比较,TC、TG、LDLC、TXA2明显降低,HDLC及PGI2明显升高;而联合治疗较单用阿托伐他汀治疗的TC、TG、LDLC、TXA2降低更明显HDLC及PGI2升高更明显,差异有统计学意义,两组患者均未出现严重毒副作用。结论 依折麦布联合阿托伐他汀治疗能够更加有效的发挥调脂、保护血管内皮功能及减轻炎性反应的作用,安全可靠。 [Abxtact] Objective The effect of atorvastatin and atorvastatin co-administration with ezetimibe on total cholesterol (TC) ,triglyc-erin(TG), low density lipoprotein cholesterol ( LDLC),high density lipoprotein cholesterol (HDLC),prostacyclin ( PGI2) and throm-boxane a 2 ( TXA2) and c reactive protein (CRP) in patients with unstable angina were compared to evaluate the advantage and disadvantage. Methods 186 patients with unstable angina enrolled from June 2012 to June 2014 were divided into atorvastatin group ( 20 mg qn) and co-administration group(atorvastatin 20 mg qn and ezetimibe 10 mg qn) randomly ; TC,LDLC,PGI2,TXA2 and CRP were measured at admission and 12 weeks after treatment. Results There was no significant difference in TC,TG, LDLC, HDLC, PGI2,TXA2 and CRP levels between. After 12 weeks, the level of TC ,TG,LDLC ,TXA2 and CRP in two groups were lower than pre-treatment,and the level of HDLC and PGI2 were higher. However,the level of TC,TG,LDLC ,TXA2 and CRP were more lower and the level of HDLC and PGI2 were more higher 12 weeks after treatment in co-administration group than atorvastatin group.There was no serious side effect in both groups. Conclusion Atorvastatin combining ezetimibe was more effect on modifying lipid ,vascular endothelial function and lowering inflammatory reaction than atorvastatin alone in unstable angina patients .
出处 《中外医疗》 2015年第8期77-80,共4页 China & Foreign Medical Treatment
关键词 依折麦布 阿托伐他汀 不稳定型心绞痛 调脂 血管内皮功能 炎性反应 Ezetimibe Atorvastatin Unstable Angina Lipid Vascular Endothelial Function C Reactive Protein
  • 相关文献

参考文献14

  • 1Celermajer DS, Sorensen KE, Bull C, et al. Endotheliumdependent dilation in the systemic arteries of asymptomatie subjects relates to coronary risk factors and their interaction[J]..J Am Coil Cardiol, 1994,24(6):1468- 1474.
  • 2Sheng X,Murphy MJ,Macdonald TM,et al. Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patiabents with diabetes mellitus:a population-based cohort study [J]..Eur J Clin Pharmacol,2012,68(8) : 1201-1208.
  • 3Paolo C,Edward TH. The pleiotmpic effects of statins (Ischemic heart disease)[J]..Current Opinion in Cardiology, 2005,20(6):541-546.
  • 4McCormack T,Harvey P,Gaunt R,et al. Incremental cholesterol reduction with ezetimibe /simvastatin,atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE):randomised controlled trial of achievement of joint british societies (JBS-2) cholesterd targets (JBS- 2) cholesterol targets[J].. IntJ Clin Pract,2010,6 (8):1052-1061.
  • 5Olijhoek JK,Hajer GR,Van Der Graaf Y,et al. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind cross-over trial[J]..J Cardiovasc Pharmacol, 2008,52(2):145-150.
  • 6柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2139
  • 7Isles GG,Paterson JR.Identifying patients at risk for coronary heart disease:implications from trims of lipid-lowering drug therapy[J]..QJM,2000,93(9):567-574.
  • 8Baigent C,Keech A,kearney PM,et al. Cholesterol treatment trialists (CTI') collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of datafrom 90,056 participants in 14 randomized trials of statins[J].. Lancet, 2005,366(9493): 1267-1278.
  • 9Miettinen TA,Gylling H,Lindbohm N,et al. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins [J]..J lab Clin Med,2003,141(2):131-157.
  • 10Pearson TA, Denke MA, McBride PE. A communitybased,randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholestemlemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial [J]..Mayo Clin Proc, 2005,80(5):587-595.

二级参考文献34

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Heidenreich PA,Alloggiamento T,Melsop K,McDonald KM,Go AS,Hlatky MA.The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes:a meta-analysis[J].J Am Coll Cardiol,2001,38 (2):478-485.
  • 3de Lemos JA,Morrow DA,Bentley JH,Omland T,Sabatine MS,McCabe CH,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J].N Engl J Med,2001,345 (14):1 014-021.
  • 4Solymoss BC,Bourassa MG,Wesolowska E,Dryda I,Theroux P,Mondor L,et al.The role of cardiac troponin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndromes[J].Clin Cardiol,1997,20 (11):934-942.
  • 5Levin ER,Gardner DG,Samson WK.Natriuretic peptides[J].N Engl J Med,1998,339 (5):321-328.
  • 6Braunwald E,Antman EM,Beasley JW,Califf RM,Cheitlin MD,Hochman JS,et al.ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)[J].Circulation,2002,106 (14):1 893-900.
  • 7Montero I,Orbe J,Varo N,Beloqui O,Monreal JI,Rodriguez JA,et al.C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells:implications for clinical and subclinical atherosclerosis[J].J Am Coll Cardiol,2006,47 (7):1 369-378.
  • 8Morrow DA,de Lemos JA,Blazing MA,Sabatine MS,Murphy SA,Jarolim P,et al.Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease[J].JAMA,2005,294 (22):2 866-871.
  • 9Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 10Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.

共引文献2154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部